Search

Your search keyword '"Shi, Zixiao"' showing total 2 results
Start Over Author "Shi, Zixiao" Language undetermined
2 results on '"Shi, Zixiao"'

1. Durable clinical responses observed from non-Hodgkin lymphoma patients treated with autologous CAR-T cells targeting CD19

Author

Bo Zhu, Qingzhu Jia, Shi Zixiao, Jing Chen, Ronglin Xie, Pin Wang, Baofeng Wei, Qi-Jing Li, Hongliang Fang, He Feng, Jin Tao, and Yarong Liu

Subjects
Cancer Research, biology, business.industry, Cancer, medicine.disease, CD19, Chimeric antigen receptor, Oncology, biology.protein, Cancer research, Medicine, Hodgkin lymphoma, Cellular immunotherapy, Car t cells, business, human activities
Abstract

3045Background: Cellular immunotherapy based on chimeric antigen receptor (CAR)-engineered T (CAR-T) cells has shown to be one of the most promising immunotherapeutic strategies for cancer treatmen...

Published
2018

2. Remission observed from a phase 1 clinical study of CAR-T therapy with safety switch targeting BCMA for patients with relapsed/refractory multiple myeloma

Author

Shi Zixiao, Bo Zhu, Qi-Jing Li, Zhi Chen, Baofeng Wei, Pin Wang, Runhong Wei, Jin Tao, Hongliang Fang, Lin Shi, He Feng, Ronglin Xie, Jing Chen, and Yarong Liu

Subjects
0301 basic medicine, Cancer Research, business.industry, medicine.disease, Chimeric antigen receptor, Clinical trial, Clinical study, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Relapsed refractory, medicine, Cancer research, Cellular immunotherapy, Car t cells, business, human activities, Multiple myeloma, B cell
Abstract

8020Background: Encouraging results are seen from several early phase clinical trials on the cellular immunotherapy based on chimeric antigen receptor (CAR)-engineered T (CAR-T) targeting B cell ma...

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results